MedPath

A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Phase 3
Completed
Conditions
Generalized Anxiety Disorder
Registration Number
NCT00236054
Lead Sponsor
Cephalon
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
440
Inclusion Criteria
  • Subjects 18 to 64 years of age (inclusive) will be eligible to participate if they satisfy the DSM-IV-TR criteria for GAD, as well as meeting the required screening and baseline visit scores for a series of psychiatric evaluations (i.e., HAM-A, HADS, MADRS and CGI-S).
Exclusion Criteria
  • Have been previously unresponsive to two or more adequate courses of pharmacological treatment for GAD
  • Have been diagnosed with any other psychiatric Axis I disorder (except GAD) as a principal diagnosis within the past six months
  • Have been diagnosed with any eating disorder within the past six months
  • Have any history of OCD, psychotic disorder, bipolar disorder or antisocial personality disorder
  • Have any history of alcohol or substance abuse within the past 3 months
  • Have any history of seizures, including febrile seizures
  • Have any history of head trauma associated with loss of consciousness within the past 15 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction of symptomatology associated with Generalized Anxiety Disorder as assessed by the change from baseline to endpoint in the total score of the HAM-A scale.
Secondary Outcome Measures
NameTimeMethod
Assessment of proportion of responders and
patients in remission according to HAM-A scores and CGI ratings by
visit, assessment of the safety and tolerability in patients with GAD

Trial Locations

Locations (19)

Pacific Institute for Medical Research, Inc.

🇺🇸

Los Angeles, California, United States

Pharmacology Research Institute

🇺🇸

Newport Beach, California, United States

Affiliated Research Institute

🇺🇸

San Diego, California, United States

Health Quest Clinical Trials

🇺🇸

San Diego, California, United States

Pacific Clinical Research Medical Group

🇺🇸

Upland, California, United States

UF Behavioral Health Clinic

🇺🇸

Jacksonville, Florida, United States

Janus Center for Psychiatric Research

🇺🇸

West Palm Beach, Florida, United States

Atlanta Institute of Medicine & Research - Atlanta Clinic

🇺🇸

Atlanta, Georgia, United States

Cunningham Clinical Research, LLC

🇺🇸

Edwardsville, Illinois, United States

LSUHSC Anxiety and Mood Disorders Clinic

🇺🇸

New Orleans, Louisiana, United States

Scroll for more (9 remaining)
Pacific Institute for Medical Research, Inc.
🇺🇸Los Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.